These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 39083598)

  • 21. Pathophysiologically based drug treatment of sickle cell disease.
    Steinberg MH
    Trends Pharmacol Sci; 2006 Apr; 27(4):204-10. PubMed ID: 16530854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fetal hemoglobin in sickle cell anemia: The Arab-Indian haplotype and new therapeutic agents.
    Habara AH; Shaikho EM; Steinberg MH
    Am J Hematol; 2017 Nov; 92(11):1233-1242. PubMed ID: 28736939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cilostazol-mediated reversion of γ-globin silencing is associated with a high level of HbF production: A potential therapeutic candidate for β-globin disorders.
    Ali H; Khan F; Musharraf SG
    Biomed Pharmacother; 2021 Oct; 142():112058. PubMed ID: 34426256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Forced TR2/TR4 expression in sickle cell disease mice confers enhanced fetal hemoglobin synthesis and alleviated disease phenotypes.
    Campbell AD; Cui S; Shi L; Urbonya R; Mathias A; Bradley K; Bonsu KO; Douglas RR; Halford B; Schmidt L; Harro D; Giacherio D; Tanimoto K; Tanabe O; Engel JD
    Proc Natl Acad Sci U S A; 2011 Nov; 108(46):18808-13. PubMed ID: 22042865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fetal haemoglobin induction in sickle cell disease.
    Paikari A; Sheehan VA
    Br J Haematol; 2018 Jan; 180(2):189-200. PubMed ID: 29143315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A molecular glue degrader of the WIZ transcription factor for fetal hemoglobin induction.
    Ting PY; Borikar S; Kerrigan JR; Thomsen NM; Aghania E; Hinman AE; Reyes A; Pizzato N; Fodor BD; Wu F; Belew MS; Mao X; Wang J; Chitnis S; Niu W; Hachey A; Cobb JS; Savage NA; Burke A; Paulk J; Dovala D; Lin J; Clifton MC; Ornelas E; Ma X; Ware NF; Sanchez CC; Taraszka J; Terranova R; Knehr J; Altorfer M; Barnes SW; Beckwith REJ; Solomon JM; Dales NA; Patterson AW; Wagner J; Bouwmeester T; Dranoff G; Stevenson SC; Bradner JE
    Science; 2024 Jul; 385(6704):91-99. PubMed ID: 38963839
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potentially therapeutic levels of anti-sickling globin gene expression following lentivirus-mediated gene transfer in sickle cell disease bone marrow CD34+ cells.
    Urbinati F; Hargrove PW; Geiger S; Romero Z; Wherley J; Kaufman ML; Hollis RP; Chambers CB; Persons DA; Kohn DB; Wilber A
    Exp Hematol; 2015 May; 43(5):346-351. PubMed ID: 25681747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduction of the clinical severity of sickle cell/beta-thalassemia with hydroxyurea: the experience of a single center in Greece.
    Loukopoulos D; Voskaridou E; Kalotychou V; Schina M; Loutradi A; Theodoropoulos I
    Blood Cells Mol Dis; 2000 Oct; 26(5):453-66. PubMed ID: 11112383
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CRISPR-Cas9 Editing of the
    Sharma A; Boelens JJ; Cancio M; Hankins JS; Bhad P; Azizy M; Lewandowski A; Zhao X; Chitnis S; Peddinti R; Zheng Y; Kapoor N; Ciceri F; Maclachlan T; Yang Y; Liu Y; Yuan J; Naumann U; Yu VWC; Stevenson SC; De Vita S; LaBelle JL
    N Engl J Med; 2023 Aug; 389(9):820-832. PubMed ID: 37646679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of fetal hemoglobin synthesis by CRISPR/Cas9-mediated editing of the human β-globin locus.
    Antoniani C; Meneghini V; Lattanzi A; Felix T; Romano O; Magrin E; Weber L; Pavani G; El Hoss S; Kurita R; Nakamura Y; Cradick TJ; Lundberg AS; Porteus M; Amendola M; El Nemer W; Cavazzana M; Mavilio F; Miccio A
    Blood; 2018 Apr; 131(17):1960-1973. PubMed ID: 29519807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 14q32 and let-7 microRNAs regulate transcriptional networks in fetal and adult human erythroblasts.
    Lessard S; Beaudoin M; Orkin SH; Bauer DE; Lettre G
    Hum Mol Genet; 2018 Apr; 27(8):1411-1420. PubMed ID: 29432581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monomethylfumarate induces γ-globin expression and fetal hemoglobin production in cultured human retinal pigment epithelial (RPE) and erythroid cells, and in intact retina.
    Promsote W; Makala L; Li B; Smith SB; Singh N; Ganapathy V; Pace BS; Martin PM
    Invest Ophthalmol Vis Sci; 2014 May; 55(8):5382-93. PubMed ID: 24825111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LIN28A expression reduces sickling of cultured human erythrocytes.
    de Vasconcellos JF; Fasano RM; Lee YT; Kaushal M; Byrnes C; Meier ER; Anderson M; Rabel A; Braylan R; Stroncek DF; Miller JL
    PLoS One; 2014; 9(9):e106924. PubMed ID: 25188417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting sickle cell disease root-cause pathophysiology with small molecules.
    Saunthararajah Y
    Haematologica; 2019 Sep; 104(9):1720-1730. PubMed ID: 31399526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human globin knock-in mice complete fetal-to-adult hemoglobin switching in postnatal development.
    McConnell SC; Huo Y; Liu S; Ryan TM
    Mol Cell Biol; 2011 Feb; 31(4):876-83. PubMed ID: 21173165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia.
    Charache S; Barton FB; Moore RD; Terrin ML; Steinberg MH; Dover GJ; Ballas SK; McMahon RP; Castro O; Orringer EP
    Medicine (Baltimore); 1996 Nov; 75(6):300-26. PubMed ID: 8982148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determinants of fetal hemoglobin response to hydroxyurea.
    Steinberg MH
    Semin Hematol; 1997 Jul; 34(3 Suppl 3):8-14. PubMed ID: 9317196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Implications of the Association of Fetal Hemoglobin with Peripheral Oxygen Saturation in Sickle Cell Disease.
    Abdulmalik O; Ataga KI
    EBioMedicine; 2017 Oct; 24():26-27. PubMed ID: 28890145
    [No Abstract]   [Full Text] [Related]  

  • 39. Antisickling property of fetal hemoglobin enhances nitric oxide bioavailability and ameliorates organ oxidative stress in transgenic-knockout sickle mice.
    Dasgupta T; Fabry ME; Kaul DK
    Am J Physiol Regul Integr Comp Physiol; 2010 Feb; 298(2):R394-402. PubMed ID: 20007516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral administration of the LSD1 inhibitor ORY-3001 increases fetal hemoglobin in sickle cell mice and baboons.
    Rivers A; Vaitkus K; Jagadeeswaran R; Ruiz MA; Ibanez V; Ciceri F; Cavalcanti F; Molokie RE; Saunthararajah Y; Engel JD; DeSimone J; Lavelle D
    Exp Hematol; 2018 Nov; 67():60-64.e2. PubMed ID: 30125603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.